Investigational vaccine generates immune response to KRAS mutations in pancreatic cancer study
An investigational vaccine helped the immune system recognize and respond to mutations that drive most pancreatic cancers, according to results from a randomized phase 2 clinical trial led by Mayo Clinic ...
24 Oct 09:27 · Medical Xpress
KRAS-targeting vaccine prompts immune responses in pancreatic cancer patients
An investigational vaccine helped the immune system recognize and respond to mutations that drive most pancreatic cancers, according to results from a randomized phase 2 clinical trial led by Mayo Clinic researchers.
24 Oct 02:22 · News-Medical
last updated on 24 Oct 19:45